Why the study?
Impella 5.5 is typically implanted under general anesthesia, which may be undesirable in critically ill, hemodynamically unstable patients.
Is surgical implantation of the Impella 5.5 device under local anesthesia feasible and safe in critically ill patients with cardiogenic shock?
Case Report (n=3)
Is surgical implantation of the Impella 5.5 device under local anesthesia feasible and safe in critically ill patients with cardiogenic shock?
Surgical implantation of the Impella 5.5 device under local anesthesia is feasible and safe in hemodynamically unstable patients with cardiogenic shock, offering an alternative to general anesthesia.
Answers are grounded in this paper and cite their sources.
Local anesthesia enables Impella 5.5 implantation in unstable cardiogenic shock; hypothesis-generating and should not yet change practice.
BACKGROUND: Surgically implanted Impella 5.5. delivers full cardiac support and left ventricular unloading for patients with heart failure. So far, the Impella device is implanted under general anesthesia (GA). MATERIAL AND METHODS: = 3 critically ill patients presented with acute heart failure in need of cardiac support. All patients suffered cardiogenic shock of varying etiology. Due to hemodynamically unstable conditions, GA was avoided. All implantations were performed solely under local anesthesia (LAS) without any regional anesthesia. RESULTS: All implantations were performed successfully under LAS with 60 mL of mepivacaine of 2% solution and ropivacaine of 1% solution (50:50 ratio). All devices were placed from the right axillary artery. One patient needed hematoma evacuation several days after surgery. No other Impella-related complication was observed. CONCLUSION: A surgical implantation of the Impella 5.5 device under LAS is feasible and safe. Despite the small number of cases, no disadvantage can be described at the present moment. Our series should encourage physicians to perform the procedure under LAS.
No takes yet. Share an insight, caveat, or question.
Eghbalzadeh et al. (2023) conducted a case report in Acute heart failure and cardiogenic shock (n=3). Impella 5.5 implantation under local anesthesia was evaluated on Successful implantation and complications.
Synapse has enriched 10 related papers. Consider them for comparative context: